UIM3:F:F-UBS ETF SICAV - FTSE 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 94.88

Change

-0.18 (-0.19)%

Market Cap

USD 0.07B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.71%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.32 (-0.21%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.40 (+0.69%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.02 (-0.11%)

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.19 (-0.17%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.30 (-0.53%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 43.12B
0ZC:F Zscaler Inc

+0.50 (+0.26%)

USD 37.92B

ETFs Containing UIM3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.65% 70% C- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.65% 69% C- 62% D
Trailing 12 Months  
Capital Gain 15.96% 67% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.96% 63% D 54% F
Trailing 5 Years  
Capital Gain 16.59% 46% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.59% 45% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 8.77% 64% D 62% D
Dividend Return 8.77% 62% D 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.14% 68% D+ 91% A-
Risk Adjusted Return 86.50% 84% B 88% B+
Market Capitalization 0.07B 26% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.